• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, April 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Testing for hepatitis C virus remains low among baby boomers

Bioengineer by Bioengineer
March 8, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A Brief Report appearing in the American Journal of Preventive Medicine looks at testing rates for Hepatitis C virus (HCV) two years after the United States Preventive Services Task Force (USPSTF) recommended it for all baby boomers, and finds rates are still very low.

Background:

  • Approximately 3.5 million people in the United States have chronic hepatitis C virus (HCV) infection.
  • Most of those (80%) are "baby boomers" (born between 1945 and 1965), and most of them are unaware of their infections despite availability of treatments that may reduce their risk of HCV-related diseases, including chronic hepatitis, cirrhosis, and liver cancer.
  • The U.S. Preventive Services Task Force (USPSTF) recommended one-time HCV testing for baby boomers in 2013.
  • In a 2013 report, the authors noted low HCV testing prevalence among baby boomers. However, it is unknown whether HCV testing has changed following the USPSTF recommendation.

Highlights from the study:

  • Investigators studies responses from nearly 24,000 baby boomers included in the National Health Interview Survey.
  • From 2013 to 2015, HCV testing prevalence among baby boomers increased slightly, from 12.3% to 13.8%.
  • Of the 76.2 million estimated baby boomers in 2015, only 10.5 million reported ever receiving HCV testing.
  • Those with Medicare plus Medicaid, Medicaid only, or military insurance had higher rates of HCV testing than the privately insured.
  • HCV testing was also greater in men versus women, and among college graduates

"Prevalence of HCV testing among baby boomers did not substantially increase and remains low two years after the USPSTF recommendation in 2013," write the authors. "These findings underscore the need for increased awareness for HCV testing among healthcare providers and baby boomers and other innovative strategies such as state-mandated HCV testing."

###

Article: Recent Hepatitis C Virus Testing Patterns Among Baby Boomers; Am J Prevent Med 10.1016/j.amepre.2017.01.033

Media Contact

David Sampson
[email protected]
@ACSNews

http://www.cancer.org

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Stoichiometric FeTe Exhibits Superconductivity Breakthrough

April 2, 2026

QSOX2 Drives Osimertinib Resistance via JUNB-ITGB4 Axis

April 2, 2026

Significant Contrail Formation Despite Low Soot

April 2, 2026

Newly Discovered Chronic Pain Circuit Unveils Potential Avenues for Innovative Treatments

April 2, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1007 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Stoichiometric FeTe Exhibits Superconductivity Breakthrough

QSOX2 Drives Osimertinib Resistance via JUNB-ITGB4 Axis

Significant Contrail Formation Despite Low Soot

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.